Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

OZANEX - Health Canada Drug Approval Details

Approvals/Health Canada/OZANEX

Authorized

STANDARD

OZANEX

Ferrer Internacional S.A.🇨🇦 Health Canada

Approval Date: Jul 4, 2025
Approval ID: 76d2de917d16e07d
Company: Ferrer Internacional S.A.
Type: Standard

Approval Details

Approval Id: 76d2de917d16e07d
Drug Approval Canada Name: OZANEX
Product Name: OZANEX
Status: Dormant
Status Date: 2024-07-11
Original Market Date: 2018-01-04
Din: 02463504
Drug Class: Human
Dosage Form: Cream
Route Of Administration: Topical
Schedule: Prescription
Ahfs: 84:04.04
Atc Original: D06AX14 OZENOXACIN
Atc Name: d 06 ax 14
Aig Number: 0159010001
Company Name: Ferrer Internacional S.A.
Company Address: Gran Via Carlos Iii,94, Barcelona, Catalonia, Spain, 08028
Company Detail Path: /organization/ferrer-internacional-s-a

Company Information

Pharmaceutical Company Name: Ferrer Internacional S.A.
Country Name: Chile
Province Name: santiago,country_cl
City Name: santiago,santiago,country_cl
Address: Av Quilin 5273

Active Ingredients

OZENOXACIN

1 % / W/W

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

76d2de917d16e07d

Type

Standard

Back to Health Canada Approvals